John R. Stuelpnagel - 01 Dec 2021 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact
Issuer symbol
TXG
Transactions as of
01 Dec 2021
Net transactions value
-$755,820
Form type
4
Filing time
03 Dec 2021, 16:51:29 UTC
Previous filing
18 Nov 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $301,022 -2,000 -0.57% $150.51 349,616 01 Dec 2021 Direct F1, F2
transaction TXG Class A Common Stock Sale $256,869 -1,700 -0.49% $151.10 347,916 01 Dec 2021 Direct F1, F3
transaction TXG Class A Common Stock Sale $166,973 -1,100 -0.32% $151.79 346,816 01 Dec 2021 Direct F1, F4
transaction TXG Class A Common Stock Sale $15,402 -100 -0.03% $154.02 346,716 01 Dec 2021 Direct F1
transaction TXG Class A Common Stock Sale $15,555 -100 -0.03% $155.55 346,616 01 Dec 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
F2 This transaction was executed in multiple trades at prices ranging from $150.00 to $150.94. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3 This transaction was executed in multiple trades at prices ranging from $151.00 to $151.30. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F4 This transaction was executed in multiple trades at prices ranging from $151.53 to $152.37. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.